Korean J Nosocomial Infect Control.  2013 Dec;18(2):39-43. 10.14192/kjnic.2013.18.2.39.

Communication of Infectious Diseases Consultant

• Kim TH
• Kim HJ

• KMID: 2256306
• DOI: http://doi.org/10.14192/kjnic.2013.18.2.39

Abstract

Infectious disease consultation contributes to optimal antibiotic use as well as improved treatment outcomes in many infectious diseases, especially severe infections like bacteremia. However, communication and language matter in consultations between clinicians. Communication barriers are even more complex among professionals who speak Korean, since there are significant challenges for practicing medicine while relying on language translations. This review aims to address some of the components that should be included in infectious diseases consultations for Korean-speaking specialists.

Keyword

Communication barriers; Consultation; Infectious diseases consultation

MeSH Terms

Bacteremia
Communicable Diseases*
Communication Barriers
Consultants*
Humans
Referral and Consultation
Specialization
Translations

Reference

References

1. Ibrahim EH, Sherman G, Ward S, Fraser VJ, Kollef MH. The influence of inadequate antimicrobial treatment of bloodstream infections on patient outcomes in the ICU setting. Chest. 2000; 118:146–55.

2. Glowacki RC, Schwartz DN, Itokazu GS, Wisniewski MF, Kieszkowski P, Weinstein RA. Antibiotic combinations with redundant antimicrobial spectra: clinical epidemiology and pilot intervention of computer-assisted surveillance. Clin Infect Dis. 2003; 37:59–64.

3. Rüttimann S, Keck B, Hartmeier C, Maetzel A, Bucher HC. Long-term antibiotic cost savings from a comprehensive intervention program in a medical department of a university-affiliated teaching hospital. Clin Infect Dis. 2004; 38:348–56.

4. Jeong IH. Our medical terminology is a mirror our times of medicine. Journal of the Korean Medical Association. 2000; 43:1034–6.

5. 이정근. 편집자에게 드리는 글: 외국말에 오염 된 대한방사선의학회지. 대한방사선의학회지. 1996; 35:1016–7.

6. Lo E, Rezai K, Evans AT, Madariaga MG, Phillips M, Brobbey W. et al. Why don't they listen? Adherence to recommendations of infectious disease consultations. Clin Infect Dis. 2004; 38:1212–8.

7. Kim BN, Jin KB, Hong YS. Compliance and impact of an ID physician's advisory consults on the use of restricted antimicrobial agents. Infect Chemother. 2004; 36:164–9.

8. Khan AR, Khan S, Zimmerman V, Baddour LM, Tleyjeh IM. Quality and strength of evidence of the Infectious Diseases Society of America clinical practice guidelines. Clin Infect Dis. 2010; 51:1147–56.

9. Yinnon AM. Whither infectious diseases consultations? Analysis of 14,005 consultations from a 5-year period. Clin Infect Dis. 2001; 33:1661–7.

10. Fowler VG Jr, Sanders LL, Sexton DJ, Kong L, Marr KA, Gopal AK. et al. Outcome of Staphylococcus aureus bacteremia according to compliance with recommendations of infectious diseases specialists: experience with 244 patients. Clin Infect Dis. 1998; 27:478–86.

11. Volk ML, Ubel PA. Better off not knowing: improving clinical care by limiting physician access to unsolicited diagnostic information. Arch Intern Med. 2011; 171:487–8.

12. Grace C, Alston WK, Ramundo M, Polish L, Kirkpatrick B, Huston C. The complexity, relative value, and financial worth of curbside consultations in an academic infectious diseases unit. Clin Infect Dis. 2010; 51:651–5.